2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND With Neoadjuvant Ipilimumab + Nivolumab?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Marlana Orloff
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Marlana Orloff
57 views
August 20, 2020
Comments 0
Login to view comments.
Click here to Login
Skin
